Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10

A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban [Corrigendum]

Authors Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, LaCreta F

Received 15 March 2018

Accepted for publication 15 March 2018

Published 11 June 2018 Volume 2018:10 Pages 71—72

DOI https://doi.org/10.2147/CPAA.S168295


Frost C, Song Y, Barrett YC, et al. Clin Pharmacol. 2014;6:179–187.

Page 183, Figure 2, the arithmetic mean apixaban trough concentration on Day 4 prior to the morning dose (ie, 0-hr Figure 2) was not correct. The arithmetic mean (SD) apixaban trough concentration on Day 4 prior to the morning dose was 24.6 (6.1) ng/mL.

Read the original article.


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]